Unlock instant, AI-driven research and patent intelligence for your innovation.

Methylindole and aromatic amino acid modified 2,5-diketopiperazines, their synthesis, activity and application

A technology of diketopiperazine and indole, which is applied to 3R--6R-[4-Lys-amino-n-butyl]-2,5-diketopiperazine, and the application field of preparing anti-tumor metastases medicine, can Solve the problems of unsatisfactory clinical efficacy of tumor chemotherapy and no anti-tumor metastasis effect

Inactive Publication Date: 2021-06-08
CAPITAL UNIVERSITY OF MEDICAL SCIENCES
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Because the existing anti-tumor drugs have no anti-tumor metastasis effect, the clinical efficacy of tumor chemotherapy is not ideal

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Methylindole and aromatic amino acid modified 2,5-diketopiperazines, their synthesis, activity and application
  • Methylindole and aromatic amino acid modified 2,5-diketopiperazines, their synthesis, activity and application
  • Methylindole and aromatic amino acid modified 2,5-diketopiperazines, their synthesis, activity and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0016] Embodiment 1 prepares D-Boc-Lys(Cbz)-Trp-OBzl

[0017] Suspend 7.7g (20mmol) D-Boc-Lys (Cbz) in 100mL of anhydrous tetrahydrofuran (THF), and add 2.7g (20mmol) 1-hydroxybenzotriazole ( HOBt) and 5.0 g (25 mmol) of dicyclohexylcarbodiimide (DCC), then stirred for 30 min. Afterwards, 8.0 g (25 mmol) D-Trp-OBzl was added. The reaction mixture was adjusted to pH 9 by adding N-methylmorpholine (NMM) dropwise. The reaction mixture was first stirred under ice bath for 1 h, and then stirred at room temperature for 12 h. The reaction mixture was filtered, the filtrate was concentrated under reduced pressure, and the residue was dissolved in 150 mL of ethyl acetate solution. The obtained ethyl acetate solution was sequentially washed with 5% KHSO 4 Wash 3 times with aqueous solution and 3 times with saturated NaCl aqueous solution. Ethyl acetate layer with anhydrous Na 2 SO 4 Dry for 12h, filter, and concentrate the filtrate to dryness under reduced pressure. The obtained...

Embodiment 2

[0018] Embodiment 2 prepares D-Lys(Cbz)-D-Trp-OBzl

[0019] 3.8 g (5 mmol) of D-Boc-Lys(Cbz)-D-Trp-OBzl was slowly mixed with 52 mL of hydrogen chloride in ethyl acetate (4M) under ice bath and stirring. The resulting solution was stirred for 5 h in an ice bath. After that, the reaction mixture was concentrated under reduced pressure. The residue was dissolved in 50 mL of anhydrous ethyl acetate, and the resulting solution was concentrated under reduced pressure. This operation was repeated three times. The residue was washed well with anhydrous ether to obtain 3.41 g (93%) of the title compound as a yellow powder. ESI-MS(m / e):557[M+H] + .

Embodiment 3

[0020] Example 3 Preparation of 3R-(indole-3-methyl)-6R-(4-benzyloxycarbonylamino-n-butyl)-2,5-diketopiperazine (1)

[0021] 3.45 g (6.2 mmol) of D-Lys(Cbz)-D-Trp-OBzl were dissolved in 150 mL of ethyl acetate. The obtained solution was washed three times with 5% aqueous sodium bicarbonate solution, and then the ethyl acetate solution was stirred at room temperature for 12 h to fully separate out the colorless solid. 1.8 g (51%) of the title compound were filtered off. ESI-MS(m / e):449[M+H] + .

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses 3R-(indole-3-methyl)-6R-[4-Lys(AA)-amino-n-butyl]-2,5-diketopiperazine of the following formula (wherein AA is L- Phe residues, L-Trp residues and L-Tyr residues), disclose their preparation methods, disclose their anti-tumor metastasis activity, and thus the present invention discloses their application in the preparation of anti-tumor metastasis drugs.

Description

technical field [0001] The present invention relates to 3R-(indole-3-methyl)-6R-[4-Lys(AA)-amino-n-butyl]-2,5-diketopiperazine. It relates to their preparation method and their anti-tumor metastasis activity, thus the present invention relates to their application in the preparation of anti-tumor metastasis drugs. The invention belongs to the field of biomedicine. Background technique [0002] Tumors seriously threaten human health. In addition to the poor prognosis of cancer patients, the concurrent metastasis of tumors further worsens the prognosis of patients. For example, more than 90% of cancer patients died of metastasis. Because the existing anti-tumor drugs have no anti-tumor metastasis effect, the clinical curative effect of tumor chemotherapy is unsatisfactory. It is an urgent clinical need to invent drugs against tumor metastasis. Previously, the inventors had disclosed that diketopiperazines with four configurations of S, S-, R, R-, R, S- and S, R- could inh...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D403/06C07K5/02C07K1/06C07K1/02A61K38/07A61P35/04
CPCA61K38/00A61P35/04C07B2200/07C07D403/06C07K5/021Y02P20/55
Inventor 赵明张筱宜彭师奇宋越
Owner CAPITAL UNIVERSITY OF MEDICAL SCIENCES